Hypoxia-sensing CAR T cells provide safety and efficacy in treating solid tumors

Paris Kosti1, James W Opzoomer1, Karen I Larios-Martinez1

  • 1School of Cancer and Pharmaceutical Sciences, King's College London, Faculty of Life Sciences and Medicine, Guy's Campus, London SE1 1UL, UK.

Insights

This study introduces a novel hypoxia-sensing chimeric antigen receptor (CAR) T-cell system. This system targets solid tumors selectively, enhancing safety and efficacy for cancer treatment.

Area of Science:

  • Immunotherapy
  • Oncology
  • Molecular Biology

Background:

  • Chimeric antigen receptor (CAR) T-cell therapy faces challenges in targeting solid tumors due to a lack of tumor-specific antigens.
  • On-target, off-tumor CAR T-cell activation can lead to severe toxicities, limiting therapeutic applications.

Purpose of the Study:

  • To develop a stringent hypoxia-sensing CAR T-cell system for selective targeting of solid tumors.
  • To overcome the limitations of CAR T-cell therapy in solid malignancies by enhancing tumor selectivity and safety.

Main Methods:

  • Engineered CAR T-cells with a hypoxia-sensing system to achieve selective CAR expression within the tumor microenvironment.
  • Utilized murine xenograft models to evaluate the anti-tumor efficacy and toxicity profile of the hypoxia-sensing CAR T-cells.

Main Results:

  • Demonstrated selective expression of a pan-ErbB-targeted CAR within solid tumors, characterized by hypoxic conditions.
  • Achieved significant anti-tumor efficacy in murine models without observable off-tumor toxicity, despite ErbB receptor expression in healthy organs.

Conclusions:

  • The hypoxia-sensing CAR T-cell system acts as a dynamic on/off safety switch, enabling targeted therapy in solid tumors.
  • This approach has the potential to expand the repertoire of CAR T-cell targets for treating various solid malignancies safely and effectively.

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
804
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.9K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.0K